NPC1-/- Mouse Model
Niemann-Pick disease type C1 is an inherited lysosomal storage disorder that affects the viscera and the central nervous system. The disease is caused by defective intracellular processing and transport of low-density lipoprotein derived cholesterol and it causes accumulation of cholesterol in lysosomes, with delayed induction of cholesterol homeostatic reactions (Mattsson et al., 2012).
Mice homozygous for the recessive NIH allele of the Niemann Pick type C1 gene (Npc1m1N) show a dual deficiency of sphingomyelinase and glucocerebrosidase activity (JAX# 003092). Animals are bred on a BALB/c OlaHsd background. For a details characterization of this mouse model see our publication Santiago-Mujica et al., 2019.
Tissue Cholesterol Levels
Total cholesterol levels were assessed in the liver and distinct brain regions of 6-week old NPC1-/- and wildtype animals. While total liver cholesterol levels were significantly increased in the liver of NPC1-/- animals compared to wildtype mice (Fig.1A), total cholesterol levels in distinct brain regions were decreased in NPC1-/- mice compared to wildtype littermates (Fig. 1B).
|Figure 1. Absence of NPC1 in mice causes changes in the tissue cholesterol content. NPC1 deletion in mice leads to cholesterol accumulation in the liver (A) and decreased total cholesterol levels in distinct brain regions (B). 6-week old NPC1-/-, n = 6 per group, mice of both sexes were used. Statistical analyses using unpaired t-test revealed significant differences in cholesterol levels between knockout and wildtype animals. Mean + SEM; *p<0.05; **p<0.01; ***p<0.001.|
Liver enzymes in NPC1-/- mice
The liver enzyme profile was assessed in the plasma of 7-week old NPC1-/- and wildtype animals. Alkaline phosphatase (AP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were significantly elevated in the plasma of NPC1-/- animals compared to wildtype mice (Fig. 2).
|Figure 2. Absence of NPC1 in mice influences liver enzyme levels. Plasma of NPC1-/- and non-transgenic animals were evaluated for AP, AST and ALT. 7-week old NPC1-/-, n = 8 per group, male mice were used. Statistical analyses using unpaired t-test revealed significant differences in liver enzyme levels between knockout and wildtype animals. Mean + SEM; ***p<0.001.|
QPS Austria offers a custom tailored study design for this model and we are flexible to accommodate to your special interest. NPC1-/- mice show relevant features of Niemann-Pick Disease already at young age. This allows for extraordinarily fast turn-around times.
We would be happy to test your compounds in the NPC1-/- mouse model! The most common readouts are:
- Tissue weight
- Cholesterol andtriglycerideslevels
- Liver enzyme levels
- Aβ levels
- Purkinje cell loss
- Muscle strength and motor deficits
- General activity
You might be also interested in these related topics
QPS Austria is also ready to provide samples (brain tissue, CSF etc.) from these animals for analyses in your laboratory.
We are happy to receive your inquiry.
Rosenbaum AI, Maxfield FR. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J Neurochem. 2011 Mar;116(5):789-95. doi: 10.1111/j.1471-4159.2010.06976.x. Epub 2011 Jan 7.
Mattsson N, Olsson M, Gustavsson MK, Kosicek M, Malnar M, Månsson E, Blomqvist M, Gobom J, Andreasson U, Brinkmalm G, Vite C, Hecimovic S, Hastings C, Blennow K, Zetterberg H, Portelius E. Amyloid-β metabolism in Niemann-Pick C disease models and patients. Metab Brain Dis. 2012 Dec;27(4):573-85. doi:10.1007/s11011-012-9332-8. Epub 2012 Sep 1.
Ohm TG, Treiber-Held S, Distl R, Glöckner F, Schönheit B, Tamanai M, Meske V. Cholesterol and tau protein–findings in Alzheimer’s and Niemann Pick C’s disease. Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S120-6.